ISRCTN27307877
已完成
不适用
Trisodium citrate versus heparin for locking tunnelled haemodialysis catheters: a randomised controlled trial
Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)0 个研究点目标入组 0 人2005年9月30日
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- 未指定
- 发起方
- Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
- 状态
- 已完成
- 最后更新
- 11年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •Any patient who require a new tunnelled catheter for haemodialysis. Patients fall into three groups:
- •1\. Patients who present to the kidney unit of the UHNS with kidney failure needing maintenance haemodialysis
- •2\. Patients who have to switch from peritoneal to haemodialysis because of problems with their peritoneal dialysis
- •3\. Existing haemodialysis patients who need tunnelled catheters because their arterivenous fistulas or tunnelled catheters have failed
- •The decision to place a tunnelled dialysis catheter is made by one of the renal consultants entirely on the basis of clinical need. Patients will be invited to take part prior to insertion of the tunnelled dialysis catheter. Randomisation will be by sealed envelopes. The only differences in dialysis care that patients will have is the locking agent, otherwise patients will have the same treatment whether they are dialysing in our main renal unit in Stoke or our two satellite units at Stafford and Leighton. They will be followed up and all dialysis\-related issues will be documented as per current practice.
排除标准
- •Not provided at time of registration
结局指标
主要结局
未指定
相似试验
尚未招募
2 期
The efficacy of trisodium citrate versus heparin for permanent cuffed tunneled catheter lock in chronic hemodialysis patientschronic hemodialysislocking solutioncitratepermanent catheterhemodialysisTCTR20230107004Faculty of Medicine Siriraj Hospital, Mahidol University148
已完成
不适用
Taurolidine-citrate vs heparin as catheter lock solutions in paediatric patientsCatheter-related infectionsInfections and InfestationsISRCTN86885538Tauropharm (Germany)100
已完成
不适用
Clinical Trial Comparing TaurolockTMHep100 (Taurolidine 1.35%) and 0.9% Saline As Prevention of Recurrent Catheter-related Bloodstream InfectionsCatheter Related Blood Stream InfectionsIntestinal FailureNCT06660641Rigshospitalet, Denmark61
进行中（未招募）
1 期
Investigating different anticoagulants for renal replacement therapyEUCTR2014-004854-33-DEniversity Hospital Muenster1,450
Unknown
不适用
The Impact of Different Citrate Concentrations as Locking Solutions on Development of Biofilm and Function of Hemodialysis CathetersEnd-Stage Kidney DiseaseRenal DialysisCentral Venous CatheterBiofilmsNCT03683563University Medical Centre Ljubljana50